Establishing a comprehensive questionnaire for detecting drug-induced extrapyramidal symptoms

Keiko Ohno, Shinsuke Miyazawa, Masayuki Hashiguchi, Tamao Unemoto, Atsuo Itoh, Hirotoshi Echizen, Tadaaki Rikihisa, Hiroyasu Ogata, Masahiro Murata

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objective: Drug-induced extrapyramidal symptoms (DIEPS) often substantially compromise quality of life (QOL) of patients receiving drugs with central antidopaminergic activities. A lack of comprehensive screening method based upon patients' subjective symptoms for detecting DIEPS appears to have prevented pharmacists from delivering satisfactory pharmaceutical care for these patients. Thus, we have attempted to develop a comprehensive questionnaire for screening patients having higher risks of developing DIEPS. Methods: One hundred fourteen outpatients taking gastroprokinetic drugs (itopride, cisapride, trimebutine, domperidone and metoclopramide) at least 2 weeks participated in the study. One patient with familial Parkinson disease served as a positive reference. They undertook a questionnaire consisting of 9 comprehensive questions written in non-technical words that were aimed to detect typical symptoms of Parkinsonism including akathisia and dyskinesia. Each symptom was scored in a semiquantitative scale [i.e., from 1 (not at all) to 5 (very much)] by the patients. Results: Of the 108 subjects who successfully completed the questionnaires, 43 gave scores 2 or greater indicating the presence of DIEPS. However, no statistically significant correlations were observed between the scores of any possible pairs of the questionnaire items. Five subjects had a mean questionnaire score of equal to or greater than 1.6, and the patient with familiar Parkinsonism had the highest mean score of 1.9. Conclusion: The questionnaire presented herein detected 4 patients with suspected DIEPS. Further studies should be warranted to assess whether it would be useful for pharmacists as a screening tool for DIEPS in patients having higher risks of DIEPS.

Original languageEnglish
Pages (from-to)881-886
Number of pages6
JournalYakugaku Zasshi
Volume123
Issue number10
DOIs
Publication statusPublished - 2003 Oct
Externally publishedYes

Fingerprint

Pharmaceutical Preparations
Parkinsonian Disorders
Pharmacists
Trimebutine
Cisapride
Domperidone
Surveys and Questionnaires
Psychomotor Agitation
Preclinical Drug Evaluations
Metoclopramide
Pharmaceutical Services
Dyskinesias
Parkinson Disease
Outpatients
Quality of Life

Keywords

  • Adverse drug reactions
  • Drug-induced extrapyramidal symptoms
  • Pharmaceutical care
  • Questionnaire

ASJC Scopus subject areas

  • Molecular Medicine

Cite this

Establishing a comprehensive questionnaire for detecting drug-induced extrapyramidal symptoms. / Ohno, Keiko; Miyazawa, Shinsuke; Hashiguchi, Masayuki; Unemoto, Tamao; Itoh, Atsuo; Echizen, Hirotoshi; Rikihisa, Tadaaki; Ogata, Hiroyasu; Murata, Masahiro.

In: Yakugaku Zasshi, Vol. 123, No. 10, 10.2003, p. 881-886.

Research output: Contribution to journalArticle

Ohno, K, Miyazawa, S, Hashiguchi, M, Unemoto, T, Itoh, A, Echizen, H, Rikihisa, T, Ogata, H & Murata, M 2003, 'Establishing a comprehensive questionnaire for detecting drug-induced extrapyramidal symptoms', Yakugaku Zasshi, vol. 123, no. 10, pp. 881-886. https://doi.org/10.1248/yakushi.123.881
Ohno, Keiko ; Miyazawa, Shinsuke ; Hashiguchi, Masayuki ; Unemoto, Tamao ; Itoh, Atsuo ; Echizen, Hirotoshi ; Rikihisa, Tadaaki ; Ogata, Hiroyasu ; Murata, Masahiro. / Establishing a comprehensive questionnaire for detecting drug-induced extrapyramidal symptoms. In: Yakugaku Zasshi. 2003 ; Vol. 123, No. 10. pp. 881-886.
@article{49b65cda18b841b48fa72a13540b589f,
title = "Establishing a comprehensive questionnaire for detecting drug-induced extrapyramidal symptoms",
abstract = "Objective: Drug-induced extrapyramidal symptoms (DIEPS) often substantially compromise quality of life (QOL) of patients receiving drugs with central antidopaminergic activities. A lack of comprehensive screening method based upon patients' subjective symptoms for detecting DIEPS appears to have prevented pharmacists from delivering satisfactory pharmaceutical care for these patients. Thus, we have attempted to develop a comprehensive questionnaire for screening patients having higher risks of developing DIEPS. Methods: One hundred fourteen outpatients taking gastroprokinetic drugs (itopride, cisapride, trimebutine, domperidone and metoclopramide) at least 2 weeks participated in the study. One patient with familial Parkinson disease served as a positive reference. They undertook a questionnaire consisting of 9 comprehensive questions written in non-technical words that were aimed to detect typical symptoms of Parkinsonism including akathisia and dyskinesia. Each symptom was scored in a semiquantitative scale [i.e., from 1 (not at all) to 5 (very much)] by the patients. Results: Of the 108 subjects who successfully completed the questionnaires, 43 gave scores 2 or greater indicating the presence of DIEPS. However, no statistically significant correlations were observed between the scores of any possible pairs of the questionnaire items. Five subjects had a mean questionnaire score of equal to or greater than 1.6, and the patient with familiar Parkinsonism had the highest mean score of 1.9. Conclusion: The questionnaire presented herein detected 4 patients with suspected DIEPS. Further studies should be warranted to assess whether it would be useful for pharmacists as a screening tool for DIEPS in patients having higher risks of DIEPS.",
keywords = "Adverse drug reactions, Drug-induced extrapyramidal symptoms, Pharmaceutical care, Questionnaire",
author = "Keiko Ohno and Shinsuke Miyazawa and Masayuki Hashiguchi and Tamao Unemoto and Atsuo Itoh and Hirotoshi Echizen and Tadaaki Rikihisa and Hiroyasu Ogata and Masahiro Murata",
year = "2003",
month = "10",
doi = "10.1248/yakushi.123.881",
language = "English",
volume = "123",
pages = "881--886",
journal = "Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan",
issn = "0031-6903",
publisher = "Pharmaceutical Society of Japan",
number = "10",

}

TY - JOUR

T1 - Establishing a comprehensive questionnaire for detecting drug-induced extrapyramidal symptoms

AU - Ohno, Keiko

AU - Miyazawa, Shinsuke

AU - Hashiguchi, Masayuki

AU - Unemoto, Tamao

AU - Itoh, Atsuo

AU - Echizen, Hirotoshi

AU - Rikihisa, Tadaaki

AU - Ogata, Hiroyasu

AU - Murata, Masahiro

PY - 2003/10

Y1 - 2003/10

N2 - Objective: Drug-induced extrapyramidal symptoms (DIEPS) often substantially compromise quality of life (QOL) of patients receiving drugs with central antidopaminergic activities. A lack of comprehensive screening method based upon patients' subjective symptoms for detecting DIEPS appears to have prevented pharmacists from delivering satisfactory pharmaceutical care for these patients. Thus, we have attempted to develop a comprehensive questionnaire for screening patients having higher risks of developing DIEPS. Methods: One hundred fourteen outpatients taking gastroprokinetic drugs (itopride, cisapride, trimebutine, domperidone and metoclopramide) at least 2 weeks participated in the study. One patient with familial Parkinson disease served as a positive reference. They undertook a questionnaire consisting of 9 comprehensive questions written in non-technical words that were aimed to detect typical symptoms of Parkinsonism including akathisia and dyskinesia. Each symptom was scored in a semiquantitative scale [i.e., from 1 (not at all) to 5 (very much)] by the patients. Results: Of the 108 subjects who successfully completed the questionnaires, 43 gave scores 2 or greater indicating the presence of DIEPS. However, no statistically significant correlations were observed between the scores of any possible pairs of the questionnaire items. Five subjects had a mean questionnaire score of equal to or greater than 1.6, and the patient with familiar Parkinsonism had the highest mean score of 1.9. Conclusion: The questionnaire presented herein detected 4 patients with suspected DIEPS. Further studies should be warranted to assess whether it would be useful for pharmacists as a screening tool for DIEPS in patients having higher risks of DIEPS.

AB - Objective: Drug-induced extrapyramidal symptoms (DIEPS) often substantially compromise quality of life (QOL) of patients receiving drugs with central antidopaminergic activities. A lack of comprehensive screening method based upon patients' subjective symptoms for detecting DIEPS appears to have prevented pharmacists from delivering satisfactory pharmaceutical care for these patients. Thus, we have attempted to develop a comprehensive questionnaire for screening patients having higher risks of developing DIEPS. Methods: One hundred fourteen outpatients taking gastroprokinetic drugs (itopride, cisapride, trimebutine, domperidone and metoclopramide) at least 2 weeks participated in the study. One patient with familial Parkinson disease served as a positive reference. They undertook a questionnaire consisting of 9 comprehensive questions written in non-technical words that were aimed to detect typical symptoms of Parkinsonism including akathisia and dyskinesia. Each symptom was scored in a semiquantitative scale [i.e., from 1 (not at all) to 5 (very much)] by the patients. Results: Of the 108 subjects who successfully completed the questionnaires, 43 gave scores 2 or greater indicating the presence of DIEPS. However, no statistically significant correlations were observed between the scores of any possible pairs of the questionnaire items. Five subjects had a mean questionnaire score of equal to or greater than 1.6, and the patient with familiar Parkinsonism had the highest mean score of 1.9. Conclusion: The questionnaire presented herein detected 4 patients with suspected DIEPS. Further studies should be warranted to assess whether it would be useful for pharmacists as a screening tool for DIEPS in patients having higher risks of DIEPS.

KW - Adverse drug reactions

KW - Drug-induced extrapyramidal symptoms

KW - Pharmaceutical care

KW - Questionnaire

UR - http://www.scopus.com/inward/record.url?scp=24944524830&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24944524830&partnerID=8YFLogxK

U2 - 10.1248/yakushi.123.881

DO - 10.1248/yakushi.123.881

M3 - Article

C2 - 14577334

AN - SCOPUS:24944524830

VL - 123

SP - 881

EP - 886

JO - Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan

JF - Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan

SN - 0031-6903

IS - 10

ER -